BofA Lifts Colgate-Palmolive (CL) Outlook as Company Begins Execution of 2030 Strategic Plan

Core Viewpoint - BofA has raised its price target for Colgate-Palmolive to $105 from $100, maintaining a Buy rating, reflecting increased confidence in the company's business momentum and the execution of its 2030 Strategic Plan [2] Group 1: Financial Performance - Colgate-Palmolive achieved growth in several financial metrics in 2025, including organic sales, net sales, gross profit, base business earnings per share, and free cash flow, despite challenges such as weaker category growth and higher raw material costs [3] - The company reported stronger-than-expected results in Q4 2025, with an optimistic outlook for 2026 marking the start of its new strategic initiatives [2][3] Group 2: Strategic Initiatives - The 2030 strategic framework focuses on five core priorities, including strengthening global brands and accelerating innovation through scientific research [3] - Colgate plans to enhance demand by improving its omnichannel capabilities and increasing the use of digital tools, data, analytics, and AI [4] - A strategic growth and productivity program has been introduced to support organizational changes and fund long-term strategies [4] Group 3: Business Segments - Colgate-Palmolive operates in multiple segments, including Oral Care, Personal Care, Home Care, and Pet Nutrition, positioning itself as a growth-focused business [5]